Tag Archives: Come

Beyond CBD: Here come the other cannabinoids, but where’s the evidence?

In the span of a few years, the component of cannabis called CBD (cannabidiol) went from being a relatively obscure molecule to a healthcare fad that has swept the world, spawning billions in sales, millions of users, CBD workout clothing, pillowcases, hamburgers, ice cream — you name it. The concerns of such a rapid adoption… Read More: Beyond CBD: Here come the other cannabinoids, but where’s the… »

It has come to this: ignore vaccines-in-animals drug industry PR & news

A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This:  Ignore the CDC,”  co-authored by former National Institutes of Health director Harold Varmus,  was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More: It has come to this: ignore vaccines-in-animals drug industry PR… »

Texas-sized problem: Gov. Abbott says tougher anti-COVID restrictions might come back

The number of new coronavirus cases and hospitalizations has increased in Texas and several states in the South and West, leading governors to eye more aggressive responses. Texas Gov. Greg Abbott said Monday that increased rates in hospitalizations and record daily highs of new coronavirus cases show that “COVID-19 is now spreading at an unacceptable… Read More: Texas-sized problem: Gov. Abbott says tougher anti-COVID restrictions might come… »

Cancer researchers come to Harvard to share findings, launch center for early detection

Amid alarming projections that global cancer rates will skyrocket, researchers from around the country gathered at Harvard on Monday to share their latest findings and to launch a center whose aim is to boost early detection and prevention. By 2040, deaths due to cancer are expected to rise 60 percent in the U.S., 79 percent… Read More: Cancer researchers come to Harvard to share findings, launch center… »